Effect of 5-aminolevulinic acid-encapsulate liposomes on photodynamic therapy in human cholangiocarcinoma cells

J Nanosci Nanotechnol. 2014 Aug;14(8):5628-32. doi: 10.1166/jnn.2014.8825.

Abstract

Intracellular protoporphyrin IX (PpIX) generation following administration of 5-aminolevulinic acid (ALA) has been used in photodynamic therapy (PDT). Subsequent irradiation can lead to selective damage to photosensitizer-treated cells or tissues. In the present work, we describe the enhancement of ALA-induced PpIX accumulation using a liposome carrier. ALA-containing liposomes (Lipo-ALA) were prepared using dipalmitoyl-phosphatidyl choline and in vitro PDT effect was investigated against human cholangiocarcinoma HuCC-T1 cells. Lipo-ALA increased the uptake efficiency into tumor cells compared to ALA itself, which increased the phototoxic effect. A positive relationship was evident between small particle size, PpIX accumulation and cell death after Lipo-ALA based PDT.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminolevulinic Acid / administration & dosage
  • Aminolevulinic Acid / therapeutic use*
  • Apoptosis
  • Cell Line, Tumor
  • Cell Separation
  • Cholangiocarcinoma / drug therapy*
  • Cholangiocarcinoma / pathology
  • Flow Cytometry
  • Humans
  • Liposomes
  • Photochemotherapy*

Substances

  • Liposomes
  • Aminolevulinic Acid